Genotypic resistance at viral rebound among patients who received lopinavir/ritonavir-based or efavirenz-based first antiretroviral therapy in South Africa. [electronic resource]
Producer: 20111207Description: 304-8 p. digitalISSN:- 1944-7884
- Adult
- Alkynes
- Anti-HIV Agents -- administration & dosage
- Antiretroviral Therapy, Highly Active -- methods
- Benzoxazines -- administration & dosage
- Cyclopropanes
- Drug Resistance, Viral
- Female
- HIV Infections -- drug therapy
- Humans
- Lopinavir -- administration & dosage
- Male
- Mutation
- RNA, Viral -- blood
- Ritonavir -- administration & dosage
- South Africa
- Treatment Failure
- Viral Load
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.